Cole Douglas G.
Insider CIK 1486373 · TTPH Director · AGIO Director · RCPT Director · QTRX Director · EDIT Director · DNLI Director · SANA Director · SGTX Director · FHTX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2026-06-24 | 2026-06-25 | 28,000 | $4.08 | $114.2K | 28,000 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2025-06-17 | 2025-06-17 | 25,000 | $4.79 | $119.8K | 25,000 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2024-06-26 | 2024-06-28 | 16,000 | $5.52 | $88.3K | 16,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2024-06-06 | 2024-07-15 | 65,000 | — | $0 | 65,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2024-06-06 | 2024-06-07 | 54,278 | — | $0 | 54,278 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | D To issuer deriv | 2023-08-11 | 2023-08-11 | 683 | $6.64 | $4.5K | 0 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | D To issuer deriv | 2023-08-11 | 2023-08-11 | 683 | $5.00 | $3.4K | 0 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2023-06-21 | 2023-06-22 | 16,000 | — | $0 | 16,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2023-06-08 | 2023-06-09 | 65,000 | — | $0 | 65,000 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2023-06-01 | 2023-06-05 | 12,649 | — | $0 | 12,649 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2023-06-01 | 2023-06-05 | 4,216 | — | $0 | 26,564 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | A Award deriv | 2023-05-19 | 2023-05-22 | 8,888 | — | $0 | 8,888 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2022-06-21 | 2022-06-22 | 16,000 | — | $0 | 16,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2022-06-06 | 2022-06-08 | 65,000 | — | $0 | 65,000 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2022-06-02 | 2022-06-06 | 17,959 | — | $0 | 17,959 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2022-06-02 | 2022-06-06 | 5,986 | — | $0 | 22,348 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | A Award deriv | 2022-05-26 | 2022-05-27 | 8,888 | — | $0 | 8,888 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2021-07-13 | 2021-07-14 | 12,530 | — | $0 | 12,530 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | A Award deriv | 2021-06-24 | 2021-06-28 | 8,888 | $9.97 | $88.6K | 8,888 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2021-06-02 | 2021-06-04 | 6,222 | — | $0 | 6,222 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2021-06-02 | 2021-06-04 | 2,074 | — | $0 | 5,327 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2021-06-01 | 2021-06-03 | 3,253 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2021-06-01 | 2021-06-03 | 3,253 | — | $0 | 3,253 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2021-02-03 | 2021-02-05 | 14,000 | — | $0 | 14,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2021-02-03 | 2021-02-18 | 23,591 | — | $0 | 23,591 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2020-06-03 | 2020-06-05 | 15,183 | — | $0 | 15,183 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2020-06-03 | 2020-06-05 | 3,253 | — | $0 | 3,253 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2019-05-30 | 2019-05-31 | 27,245 | — | $0 | 27,245 | SEC↗ |
| QTRX Quanterix Corp | A Award deriv | 2019-01-02 | 2019-01-04 | 7,900 | — | $0 | 7,900 | SEC↗ |
| QTRX Quanterix Corp | A Award | 2019-01-02 | 2019-01-04 | 2,270 | — | $0 | 4,540 | SEC↗ |
| QTRX Quanterix Corp | A Award deriv | 2018-08-07 | 2018-08-09 | 7,900 | — | $0 | 7,900 | SEC↗ |
| QTRX Quanterix Corp | A Award | 2018-08-07 | 2018-08-09 | 2,270 | — | $0 | 2,270 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2018-06-13 | 2018-06-15 | 27,830 | — | $0 | 27,830 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2017-12-07 | 2017-12-08 | 47,165 | — | $0 | 47,165 | SEC↗ |
| EDIT Editas Medicine, Inc. | J Other | 2017-08-17 | 2017-08-21 | 1,686 | — | $0 | 3,171 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2017-06-15 | 2017-06-19 | 11,538 | — | $0 | 11,538 | SEC↗ |
| EDIT Editas Medicine, Inc. | J Other | 2016-08-11 | 2016-08-15 | 1,485 | — | $0 | 1,485 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | J Other | 2016-08-10 | 2016-08-11 | 917 | — | $0 | 2,778 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2016-06-21 | 2016-06-23 | 8,000 | — | $0 | 31,125 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2015-06-23 | 2015-06-25 | 10,625 | — | $0 | 23,125 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | J Other | 2014-06-23 | 2014-06-25 | 1,861 | — | $0 | 1,861 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2014-05-30 | 2014-06-05 | 12,500 | — | $0 | 12,500 | SEC↗ |
| RCPT Receptos, Inc. | A Award deriv | 2013-07-17 | 2013-07-19 | 18,800 | — | $0 | 18,800 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2013-03-25 | 2013-05-20 | 20,000 | — | $0 | 20,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2013-03-25 | 2013-03-27 | 20,000 | — | $0 | 20,000 | SEC↗ |